|
KCMF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.414500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.942600E-03 |
| Normal-vs-Stage2 |
4.570300E-02 |
| Normal-vs-Stage3 |
1.169310E-04 |
| Normal-vs-Stage4 |
2.205600E-04 |
| Stage1-vs-Stage2 |
8.223800E-01 |
| Stage1-vs-Stage3 |
4.646300E-02 |
| Stage1-vs-Stage4 |
8.498300E-02 |
| Stage2-vs-Stage3 |
2.731600E-01 |
| Stage2-vs-Stage4 |
3.552200E-01 |
| Stage3-vs-Stage4 |
9.506800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.60700000000947E-05 |
| Normal-vs-AfricanAmerican |
5.516000E-01 |
| Normal-vs-Asian |
8.076400E-02 |
| Caucasian-vs-AfricanAmerican |
1.002810E-01 |
| Caucasian-vs-Asian |
1.489970E-01 |
| AfricanAmerican-vs-Asian |
6.480000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.215000E-03 |
| Normal-vs-Female |
3.967000E-04 |
| Male-vs-Female |
8.126800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.624400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.773500E-04 |
| Normal-vs-Age(61-80Yrs) |
6.178400E-04 |
| Normal-vs-Age(81-100Yrs) |
3.638200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.791200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.944820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.855000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.268600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.399200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.212000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.009590E-01 |
| Classical-VS-Follicular |
4.843000E-01 |
| Classical-VS-Other |
9.618400E-01 |
| Classical-VS-Normal |
1.097630E-02 |
| Tall-VS-Follicular |
3.363600E-01 |
| Tall-VS-Other |
3.820200E-01 |
| Tall-VS-Normal |
7.790500E-04 |
| Follicular-VS-Other |
7.991000E-01 |
| Follicular-VS-Normal |
9.077500E-03 |
| Other-VS-Normal |
2.944200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.577710E-04 |
| Normal-vs-N1 |
3.954600E-04 |
| N0-vs-N1 |
4.018800E-01 |
|
|
